• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A fatal case of daclizumab-induced liver failure in a patient with MS.

作者信息

Stettner Mark, Gross Catharina C, Mausberg Anne K, Pul Refik, Junker Andreas, Baba Hideo A, Schulte-Mecklenbeck Andreas, Wiendl Heinz, Kleinschnitz Christoph, Meuth Sven G

机构信息

Department of Neurology (M.S., A.K.M., R.P., C.K.), University Hospital Essen; Clinic of Neurology with Institute of Translational Neurology (C.C.G., A.S.-M., H.W., S.G.M.), University Hospital Münster, University Münster; Institute of Neuropathology (A.J.), University Hospital Essen; and Institute of Pathology (H.A.B.), University Hospital Essen, Germany.

出版信息

Neurol Neuroimmunol Neuroinflamm. 2019 Jan 21;6(2):e539. doi: 10.1212/NXI.0000000000000539. eCollection 2019 Mar.

DOI:10.1212/NXI.0000000000000539
PMID:30800722
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6369971/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c1/6369971/13cb5c5f40eb/NEURIMMINFL2018017947f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c1/6369971/13cb5c5f40eb/NEURIMMINFL2018017947f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c1/6369971/13cb5c5f40eb/NEURIMMINFL2018017947f1.jpg

相似文献

1
A fatal case of daclizumab-induced liver failure in a patient with MS.1例多发性硬化症患者因使用达利珠单抗导致肝衰竭死亡的病例。
Neurol Neuroimmunol Neuroinflamm. 2019 Jan 21;6(2):e539. doi: 10.1212/NXI.0000000000000539. eCollection 2019 Mar.
2
Daclizumab in multiple sclerosis.达利珠单抗治疗多发性硬化症。
Rev Neurol. 2018 Apr 16;66(8):271-282.
3
A case of immune-mediated encephalitis related to daclizumab therapy.一例与达利珠单抗治疗相关的免疫介导性脑炎。
Mult Scler. 2019 Apr;25(5):750-753. doi: 10.1177/1352458518792403. Epub 2018 Aug 3.
4
Daclizumab-induced adverse events in multiple organ systems in multiple sclerosis.在多发性硬化症中，达利珠单抗引起的多器官系统不良事件。
Neurology. 2014 Mar 18;82(11):984-8. doi: 10.1212/WNL.0000000000000222. Epub 2014 Feb 14.
5
Immune-mediated encephalitis with daclizumab: The final nail.免疫介导性脑炎合并达克珠单抗治疗：盖棺定论。
Mult Scler. 2019 Apr;25(5):753-754. doi: 10.1177/1352458518791374. Epub 2018 Aug 3.
6
FDA-approved drugs for multiple sclerosis have no efficacy or disability data in non-Caucasian patients.美国食品药品监督管理局批准的多发性硬化症药物在非高加索患者中没有疗效或残疾数据。
CNS Spectr. 2019 Jun;24(3):279-280. doi: 10.1017/S1092852918001517. Epub 2019 Jan 3.
7
The development of sarcoidosis in patients receiving daclizumab: A case series from multiple clinical trials.接受达利珠单抗治疗的患者发生肉样瘤病：来自多个临床试验的病例系列。
Respir Med. 2019 Mar;149:23-27. doi: 10.1016/j.rmed.2019.01.015. Epub 2019 Feb 1.
8
Pulmonary Sarcoidosis in a patient with Multiple Sclerosis on daclizumab monotherapy.多发性硬化症患者在接受达利珠单抗单药治疗时发生肺结节病。
Mult Scler Relat Disord. 2018 Feb;20:25-27. doi: 10.1016/j.msard.2017.12.011. Epub 2017 Dec 18.
9
Severe meningo-/encephalitis after daclizumab therapy for multiple sclerosis.多发性硬化症患者接受达利珠单抗治疗后出现严重脑膜脑炎。
Mult Scler. 2019 Oct;25(12):1618-1632. doi: 10.1177/1352458518819098. Epub 2019 Jan 18.
10
Circulating lymphocyte levels and relationship with infection status in patients with relapsing-remitting multiple sclerosis treated with daclizumab beta.在接受达利珠单抗β治疗的复发性缓解型多发性硬化症患者中，循环淋巴细胞水平及其与感染状态的关系。
Mult Scler. 2018 Nov;24(13):1725-1736. doi: 10.1177/1352458517729464. Epub 2017 Sep 15.

引用本文的文献

1
The role of CD56 NK cells in neurodegenerative disorders.CD56NK 细胞在神经退行性疾病中的作用。
J Neuroinflammation. 2024 Feb 13;21(1):48. doi: 10.1186/s12974-024-03040-8.
2
Management of MS Patients Treated With Daclizumab - a Case Series of 267 Patients.使用达克珠单抗治疗的多发性硬化症患者的管理——267例患者的病例系列
Front Neurol. 2020 Sep 8;11:996. doi: 10.3389/fneur.2020.00996. eCollection 2020.
3
Failed, Interrupted, or Inconclusive Trials on Immunomodulatory Treatment Strategies in Multiple Sclerosis: Update 2015-2020.

本文引用的文献

1
A case of immune-mediated encephalitis related to daclizumab therapy.一例与达利珠单抗治疗相关的免疫介导性脑炎。
Mult Scler. 2019 Apr;25(5):750-753. doi: 10.1177/1352458518792403. Epub 2018 Aug 3.
2
GFAPα IgG-associated encephalitis upon daclizumab treatment of MS.达利珠单抗治疗多发性硬化症时出现的与GFAPα IgG相关的脑炎。
Neurol Neuroimmunol Neuroinflamm. 2018 Jul 13;5(5):e481. doi: 10.1212/NXI.0000000000000481. eCollection 2018 Sep.
3
Drug reaction with eosinophilia and systemic symptoms after daclizumab therapy in MS.多发性硬化症患者接受达利珠单抗治疗后出现伴有嗜酸性粒细胞增多和全身症状的药物反应。
多发性硬化症免疫调节治疗策略的失败、中断或不确定临床试验：2015-2020 年更新。
BioDrugs. 2020 Oct;34(5):587-610. doi: 10.1007/s40259-020-00435-w.
4
Ocrelizumab initiation in patients with MS: A multicenter observational study.奥瑞珠单抗治疗多发性硬化症患者的起始治疗：一项多中心观察性研究。
Neurol Neuroimmunol Neuroinflamm. 2020 Apr 9;7(4). doi: 10.1212/NXI.0000000000000719. Print 2020 Jul.
Neurol Neuroimmunol Neuroinflamm. 2018 Jul 10;5(5):e479. doi: 10.1212/NXI.0000000000000479. eCollection 2018 Sep.
4
Drug reaction with eosinophilia and systemic symptoms after daclizumab therapy.达利珠单抗治疗后出现伴嗜酸性粒细胞增多和全身症状的药物反应。
Neurology. 2018 Jul 24;91(4):e359-e363. doi: 10.1212/WNL.0000000000005854. Epub 2018 Jun 22.
5
Importance of Medication Reconciliation: Tizanidine-Induced Hepatitis.用药核对的重要性：替扎尼定诱发的肝炎。
Am J Ther. 2017 Sep/Oct;24(5):e623-e624. doi: 10.1097/MJT.0000000000000497.
6
Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation.白细胞介素-2受体调节可重建多发性硬化症中自然杀伤细胞介导的T细胞活性受损。
Proc Natl Acad Sci U S A. 2016 May 24;113(21):E2973-82. doi: 10.1073/pnas.1524924113. Epub 2016 May 9.
7
Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECTION): a multicentre, randomised, double-blind extension trial.达利珠单抗高产工艺治疗复发缓解型多发性硬化症（SELECTION）：一项多中心、随机、双盲扩展试验。
Lancet Neurol. 2014 May;13(5):472-81. doi: 10.1016/S1474-4422(14)70039-0. Epub 2014 Mar 19.
8
The DRESS syndrome: a literature review.药物反应伴嗜酸性粒细胞增多和全身性症状（DRESS）综合征：文献综述。
Am J Med. 2011 Jul;124(7):588-97. doi: 10.1016/j.amjmed.2011.01.017. Epub 2011 May 17.
9
Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones.补体受体 2/CD21- 人幼稚 B 细胞中主要包含自身反应性无应答克隆。
Blood. 2010 Jun 17;115(24):5026-36. doi: 10.1182/blood-2009-09-243071. Epub 2010 Mar 15.
10
Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome.人疱疹病毒6型再激活与药物性超敏反应综合征的发作及严重程度的关联
Br J Dermatol. 2007 Nov;157(5):934-40. doi: 10.1111/j.1365-2133.2007.08167.x. Epub 2007 Sep 13.